Drupal.behaviors.print = function(context) {window.print();window.close();}>
Insight Genetics Snags $193K NCI SBIR Grant to Develop CDx for ALK Resistance
October 05, 2011
Insight Genetics Snags $193K NCI SBIR Grant to Develop CDx for ALK Resistance
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
NCI Awards Contracts to Insight Genetics to Develop NSCLC CDx
November 12, 2012 / GenomeWeb Daily News
Qiagen Gains Approval in Japan for EGFR Companion Dx, Acquires Rights to New Markers
January 10, 2012 / GenomeWeb Daily News
Insight Genetics Wins $200K Contract from NCI
November 9, 2010 / GenomeWeb Daily News
Dx Focus: Insight Genetics Chosen for NCI Clinical Assay Development Program
April 4, 2013 / PCR Insider
Insight Genetics to Participate in NCI's Program to Move Assays to Clinical Trials
April 3, 2013 / GenomeWeb Daily News